Gallman Cari bought BMY

March 10, 2024 · Form 4 insider transaction

Gallman Cari bought 2,094 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

2,094

Price

$0.00

Total value

N/A

InsiderGallman Cari

Role—

CompanyBristol-Myers Squibb Company (BMY)

SecurityCommon Stock, $0.10 par value

Transaction codeM: Option exercise

Transaction dateMarch 10, 2024

Filing dateMarch 12, 2024

Shares owned after2,655

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

View the original Form 4 on SEC EDGAR